Safety of Argatroban Infusion in Conduction Disturbances
NCT05740371
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Stable Coronary Artery Disease (CAD)
Unstable Angina (Troponin Negative)
Interventions
DRUG:
Argatroban
Sponsor
Tanabe Pharma GmbH